Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source
Correction to: <i>C9orf72</i> poly(glycine-alanine) knock-in mice exhibit mild rotarod and proteomic changes consistent with amyotrophic lateral sclerosis/frontotemporal dementia. [PDF]
europepmc +1 more source
Epidermicin NI01 demonstrates potent <i>in vivo</i> activity in a murine model of methicillin-resistant <i>Staphylococcus aureus</i> skin infection. [PDF]
Bennett V +6 more
europepmc +1 more source
An Assessment of the Provision of Vaping Products by UK Stop Smoking Services Using Data From Freedom of Information Requests. [PDF]
Fearon IM, Millar J, Dunne J, Murphy M.
europepmc +1 more source
Assessment of differences in immune responses to albumin compared with crystalloids for resuscitation in sepsis. [PDF]
Cafferkey J +10 more
europepmc +1 more source
Childhood socio-emotional and cognitive development and adolescents NEET (not in education, employment or training): findings from the UK Millennium Cohort Study. [PDF]
Akanni L +10 more
europepmc +1 more source

